Literature DB >> 18825343

Central mechanisms III: neuronal mechanisms of action of centrally acting antitussives using electrophysiological and neurochemical study approaches.

K Takahama1, T Shirasaki, F Soeda.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 18825343     DOI: 10.1007/978-3-540-79842-2_11

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


× No keyword cloud information.
  4 in total

1.  Synthesis and receptor profiling of Stemona alkaloid analogues reveal a potent class of sigma ligands.

Authors:  Kevin J Frankowski; Vincent Setola; Jon M Evans; Ben Neuenswander; Bryan L Roth; Jeffrey Aubé
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

2.  Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Takuya Saito; Yushiro Yamashita; Akemi Tomoda; Takashi Okada; Hideo Umeuchi; Saki Iwamori; Satoru Shinoda; Akiko Mizuno-Yasuhira; Hidetoshi Urano; Izumi Nishino; Kazuhiko Saito
Journal:  BMC Psychiatry       Date:  2020-11-10       Impact factor: 3.630

3.  Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study.

Authors:  Tsuyoshi Sasaki; Kenji Hashimoto; Masumi Tachibana; Tsutomu Kurata; Keiko Okawada; Maki Ishikawa; Hiroshi Kimura; Hideki Komatsu; Masatomo Ishikawa; Tadashi Hasegawa; Akihiro Shiina; Tasuku Hashimoto; Nobuhisa Kanahara; Tetsuya Shiraishi; Masaomi Iyo
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-24       Impact factor: 2.570

4.  Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study.

Authors:  Tsuyoshi Sasaki; Kenji Hashimoto; Masumi Tachibana; Tsutomu Kurata; Hiroshi Kimura; Hideki Komatsu; Masatomo Ishikawa; Tadashi Hasegawa; Akihiro Shiina; Tasuku Hashimoto; Nobuhisa Kanahara; Tetsuya Shiraishi; Masaomi Iyo
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-05       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.